A national milestone ahead of UAE National Day: The UAE’s new TILs program eliminates the need to travel abroad for cutting-edge cancer care. Cells taken from a patient’s own tumor are multiplied & reinfused to precisely attack cancer. #HealthcareInnovation #TILTherapy #UAE

UAE Develops Chemotherapy Alternative Read more: lafz.com.pk/news/21195/abu-d… #UAE #Cancer #TilTherapy

Chris from OPE! It’s Mow Time is selling the OPE hat to raise funds for our work on TIL therapy — using a patient’s own immune cells to fight cancer. 👉 Grab a hat, support research: opeitsmowtime.com/opetober Learn more: med.umn.edu/cge/til #CancerResearch #TILtherapy

One administration of lifileucel led to disease stability for many with recurrent/metastatic HNSCC. 🔸 DCR = 76% ✍️ @RobertFerrisMD, et al ascopost.com/news/september-… #headandneckcancer #TILtherapy #celltherapy

Sumanta Pal Discusses TIL Therapy’s Impact Beyond Melanoma With @kmmahuron oncodaily.com/science/til-th… @montypal @cityofhope #Melanoma #TILTherapy #CityofHope #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

Second procurement done! This time with @DrGopalIyer ! Needless to say the team effort involving different surgeons - it’s been a fun journey getting here and looking forward to more exciting times ahead! @IovanceBio #TIL #TILtherapy #celltherapy

Talking about #TilTherapy and #ClinicalTrials with long-term #Cholangioarcinoma survivor, Melinda Bachini from the @curecc in Ep. 3-4 on #TILtalks 🎤 tiltalks.com/

ICYMI: The NOC/c was issued based on results of the completed phase 2 C-144-01 clinical trial (NCT02360579). #melanoma #TILTherapy #TumorInfiltratingLymphocytes #celltherapy @IovanceBio Read more: hubs.li/Q03DYHX-0

Tumor-infiltrating lymphocyte therapy may offer a potentially individualized immunotherapeutic option for patients with advanced melanoma, according to Muhammad Umair Mushtaq, MD. hubs.li/Q03DK9cm0 #melsm #TILtherapy | @mumairmushtaq @KUMedCenter

The NOC/c was issued based on results of the completed phase 2 C-144-01 clinical trial (NCT02360579). #melanoma #TILTherapy #TumorInfiltratingLymphocytes #celltherapy @IovanceBio Read more: hubs.li/Q03DtVnC0

We’re honored to attend the Vrani-CURE Bash Sept 6. Our own Dr. Branden Moriarity & Dr. Beau Webber will share advances in TIL therapy fueling breakthroughs in cancer care. med.umn.edu/cge/til #TILTherapy #CancerResearch

We're excited to highlight a new review co-authored by TIL Working Group co-chair Dr. Krishna Komanduri in the American Journal of Clinical Dermatology. The publication discusses #TILtherapy innovations and their impact on #melanoma treatment. Read here: bit.ly/441VCb7

New Facebook Group! We’ve created a space for anyone interested in TIL therapy. ✅ Not affiliated with Iovance 💬 Real stories, support & awareness facebook.com/share/g/16gr5f4… #Amtagvi #Lifileucel #TILtherapy #Immunotherapy #CancerBreakthrough #TogetherAgainstCancer

How do you “Protect Your Neck”? Talking Vitiligo and life in the SUN after #TILtherapy on #TILtalks visit tiltalks.com/ for more. #MucosalMelanomaSurvivor #yourTILspeaker #EndCancer #CGT

👀 Look who’s on the front page! UMN’s genome-engineered TIL therapy helped a MN woman beat metastatic cancer. When funding fell through, the team doubled down. Innovation + resilience = Minnesota strong. 🎯 startribune.com/u-pivots-aft… #CRISPR #TILtherapy #GenomeEngineering #UMN

Excited to share our recent publication in @tandfmedicine, a single-center, open-label phase II pilot trial evaluating the in vivo persistence, efficacy, and safety of #TILtherapy after reduced-dose Flu/Cy LD in melanoma. @mumairmushtaq @MoffittNews doi.org/10.1080/14796694.202…